Myriad Genetics, Inc. Skyrocketed
Wed, Aug 06, 2025 at 07:40 PM
Myriad Genetics, Inc. (MYGN:NASDAQ) rocketted at $5.67, representing a gain of 46.5%. On Wed, Aug 06, 2025, MYGN:NASDAQ hit a New 2-Week High of $5.67. The stock appeared on our News Catalysts scanner on Wed, Aug 06, 2025 at 03:58 PM in the 'MISCELLANEOUS' category. From Wed, Jul 23, 2025, the stock recorded 30.00% Up Days and 36.36% Green Days
About Myriad Genetics, Inc. (MYGN:NASDAQ)
Myriad Genetics Inc is a molecular diagnostic company. It develops and markets novel predictive medicine, personalized medicine and prognostic medicine tests. It also provides physicians with information to solve unmet medical needs.
Top 10 Gainers:
- Ikena Oncology, Inc. (IKNA:NASDAQ), 1152.55%
- Safe & Green Holdings Corp. (SGBX:NASDAQ), 89.86%
- BiomX Inc. (PHGE:NYSEMKT), 49.43%
- Myriad Genetics, Inc. (MYGN:NASDAQ), 46.51%
- Linkhome Holdings Inc. (LHAI:NASDAQ), 45.94%
- eHealth, Inc. (EHTH:NASDAQ), 45.57%
- Grocery Outlet Holding Corp. (GO:NASDAQ), 42.7%
- Real Messenger Corporation (RMSG:NASDAQ), 39.16%
- Genius Group Limited (GNS:NYSEMKT), 34.12%
- LivePerson, Inc. (LPSN:NASDAQ), 32.93%